Rheumatological complications associated with the use of indinavir and other protease inhibitors

Benzer Materyaller

• Pharmacokinetics of the Protease Inhibitor Indinavir in Human Immunodeficiency Virus Type 1-Infected Children
  Yazar:: Burger, David M., ve diğerleri
  Baskı/Yayın Bilgisi: (2001)
• HIV Protease Inhibitors, Indinavir or Nelfinavir, Augment Antimalarial Action of Artemisinin in vitro
  Yazar:: Mishra, Lokesh C., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Human Immunodeficiency Virus Type 1 Protease Cleavage Site Mutations Associated with Protease Inhibitor Cross-Resistance Selected by Indinavir, Ritonavir, and/or Saquinavir
  Yazar:: Côté, Hélène C. F., ve diğerleri
  Baskı/Yayın Bilgisi: (2001)
• Potency of Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) Used in Combination with Other Human Immunodeficiency Virus NNRTIs, NRTIs, or Protease Inhibitors
  Yazar:: King, Robert W., ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Effect of α(1)-acid glycoprotein on the intracellular accumulation of the HIV protease inhibitors saquinavir, ritonavir and indinavir in vitro
  Yazar:: Jones, K, ve diğerleri
  Baskı/Yayın Bilgisi: (2001)